Magnificent 7 Stocks Remain Resilient Amid AI Financing Concerns February 3, 2026

Magnificent 7 Stocks Remain Resilient Amid AI Financing Concerns

Market Performance Overview

The Magnificent 7 technology stocks demonstrated resilience in December 2025, recovering with a 0.2% gain following a challenging November that saw a 1.9% decline. While the group of stocks slightly underperformed the S&P 500’s 0.3% return, it managed to outpace the NASDAQ, which fell 0.1% during the month. This performance occurred amid ongoing investor rotation from technology stocks into financials and industrials, driven by profit-taking activities and concerns over high valuations in the technology sector.


Mixed Individual Performance Amid Sector Challenges

December 2025 revealed divergent performance within the Magnificent 7 group. NVIDIA emerged as the standout performer with a 5.4% gain, bolstered by the US government’s decision to allow sales of its H200 chips to China. However, major AI infrastructure companies faced headwinds, with Google declining 2.1%, Microsoft falling 1.7%, and Amazon dropping 1.0%. These declines reflected broader market concerns about financing challenges for AI infrastructure projects, particularly following Blue Owl Capital’s exit from a $10 billion deal intended to fund Oracle’s data centre project.


Investment Outlook and Supporting Factors

Phillip Securities Research maintains an OVERWEIGHT recommendation on the Magnificent 7 stocks, citing several supportive factors for continued outperformance. The Federal Reserve’s 25 basis point interest rate cut in December provided crucial support for higher equity valuations, particularly benefiting growth-driven technology stocks. The research firm believes that all Magnificent 7 companies except Tesla will continue to deliver earnings growth that outpaces both the S&P 500 and NASDAQ 100 indices.


Future Growth Catalysts

Several tailwinds are expected to drive continued growth for the Magnificent 7. Increasing demand for artificial intelligence solutions from sovereign nations presents significant expansion opportunities. Additionally, the US government’s AI Action Plan, unveiled in July 2025, provides policy support for the sector’s development. Further monetary policy accommodation is anticipated, with more rate cuts expected in 2026, which should continue supporting valuations for growth-oriented technology stocks.


Frequently Asked Questions

Q: How did the Magnificent 7 perform in December 2025?
A: The Magnificent 7 recovered with a 0.2% gain in December 2025, following a 1.9% decline in November. This performance slightly underperformed the S&P 500 but outperformed the NASDAQ.

Q: Which Magnificent 7 stock performed best in December?
A: NVIDIA was the top performer with a 5.4% gain, driven by US approval for sales of its H200 chips to China.

Q: What challenges did AI infrastructure stocks face?
A: AI infrastructure stocks like Google, Microsoft, and Amazon declined due to concerns about financing challenges for AI infrastructure projects, highlighted by Blue Owl Capital’s exit from a $10 billion Oracle data centre funding deal.

Q: What is Phillip Securities Research’s recommendation on the Magnificent 7?
A: Phillip Securities Research maintains an OVERWEIGHT recommendation on the Magnificent 7 stocks.

Q: What factors support the positive outlook for these stocks?
A: Supporting factors include the Federal Reserve’s 25 basis point rate cut, expected continued earnings outperformance versus major indices, greater AI demand from sovereign nations, the US government’s AI Action Plan, and anticipated additional rate cuts in 2026.

Q: Why are investors rotating out of technology stocks?
A: Investors are rotating funds from technology into financials and industrials due to profit-taking and concerns about high valuations in technology stocks.

Q: Which Magnificent 7 company is expected to underperform in earnings growth?
A: Tesla is the only Magnificent 7 company that is not expected to outperform the S&P 500 and NASDAQ 100 in earnings growth according to the research.


This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst. 

 

Disclaimer

These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.

Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.

Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com